Daily global market intelligence · Tuesday edition

Aman's Global Market Intelligence — 2026-08-18

Generated 08:30 CEST (Europe/Rome) · data cutoff 08:22 CEST / 06:22 UTC. U.S. cash prices are Monday closes; futures and commodities are live indications; Asian indices are near-close/live. Europe had not opened. At 08:30 Italy, today's 08:30 ET U.S. releases were still six hours away.

REGIME: RISK-OFF / EVENT-DRIVENOil + yields vetoPaper tracking · initial two weeks

1 · Executive dashboard

S&P 500 · Mon close7,745.06−0.52%
Nasdaq Composite26,644.91−0.32%
Dow53,459.78−0.51%
Russell 20003,057.54−0.35%
VIX15.19+6.60% vol
U.S. 2Y / 10Y4.19% / 4.72%Treasury · Aug 17
Dollar index99.68+0.01% overnight
WTI / Brent$85.42 / $91.65+1.09% / +0.86%
Gold futures$4,449.90+0.73%
S&P / Nasdaq fut.−0.43% / −0.83%tech underperforms
Region / indexLevelMoveSession status
Japan · Nikkei 22567,528.59−1.72%Near close, 06:17 UTC
Hong Kong · Hang Seng25,441.67+1.29%Live
China · Shanghai Composite3,975.44+1.23%Live
South Korea · Kospi6,840.69−1.97%Near close; highly volatile
Euro Stoxx 506,530.45−0.14%Monday close; Europe pre-open
Germany · DAX26,338.61−0.38%Monday close
UK · FTSE 10010,720.30−0.28%Monday close

Three key developments

  1. Oil shock intensified: WTI $85.42 and Brent $91.65 at cutoff after Monday's Iran/Hormuz tension drove equities lower; energy inflation and margin risk now dominate. Yahoo live recap
  2. Duration assets lose support: official Treasury 2Y/10Y were 4.19%/4.72% on Aug. 17, while Nasdaq futures underperformed at −0.83%. U.S. Treasury
  3. Asia split: Japan and Korea fell while Hong Kong/Shanghai rose, arguing against a single global-beta trade.

Regime logic

Risk-off / event-driven

VIX is only 15.19—not panic—but oil above the prior $85 invalidation, a 4.72% 10Y and red U.S. futures make the previous selective risk-on label untenable. Preserve optionality; require cash-session confirmation before any long.

2 · Market drivers

Macro & central banks

  • Today's 08:30 ET U.S. housing starts/permits and import/export prices, 09:15 ET industrial production, and 10:00 ET pending home sales all occur after publication. BLS schedule · Econoday calendar
  • Wednesday 14:00 ET July FOMC minutes are the next policy gate; the Fed confirms the July 28–29 meeting and Sept. 15–16 decision. Federal Reserve
  • The official Aug. 17 Treasury curve was 4.19% at 2Y, 4.72% at 10Y and 5.31% at 30Y: long-end pressure is a valuation headwind.

Geopolitics, rates & commodities

  • Monday's U.S. decline followed renewed Iran-war/Hormuz concerns and Brent touching $90; Brent is now $91.65 at cutoff. This is both inflationary and growth-negative.
  • Gold +0.73% and a flat dollar point to hedging demand rather than a simple USD liquidity shock.
  • Risk-off would deepen if WTI holds above $85 and 10Y exceeds 4.75%; relief needs de-escalation plus WTI back below $82.

Earnings, rotation & unusual moves

  • Monday semis were internally divergent: MU +4.13%, MRVL +5.54%, ANET +1.50%, but NVDA −0.07%, AMD −1.63% and AVGO −0.14%. This is stock selection, not blanket AI strength.
  • QBTS −23.43% was the verified quantum outlier; no primary catalyst captured this morning justifies assigning causality, so treat it as price/volume risk, not news inference.
  • Home Depot/retail earnings and tonight's Keysight results can test consumer and test-equipment demand. Yahoo's calendar lists KEYS after market; recheck company IR before execution. Calendar

Regulation & positioning

  • IonQ's Q2 release cites MOU activity and a Needham conference Aug. 19; MOUs are not binding revenue and conference appearances are not product validation. IonQ IR
  • Rigetti's proposed U.S. funding is only an LOI and contemplates government equity, explicitly creating dilution risk. Rigetti Q2

3 · Theme dashboards

AI / semiconductors / cloud / power

Relative leaders: MU, MRVL Quality: VRT Gate: NVDA

  • NVDA $225.01: flat Monday; official Q2 FY27 results are Aug. 26 at 14:00 PT. The event is the sector's biggest 7–30 day valuation gate. NVIDIA IR
  • VRT $292.43: Q2 sales $3.274B (+24%), adjusted margin 22.6% (+410 bp), adjusted FCF $925M and raised guidance support the power/cooling thesis. Counter: project timing, capex crowding and premium valuation. Vertiv IR
  • AMD $506.00: Q2 revenue $11.536B (+50%) and data-center revenue $6.718B (+107%) are strong; Monday −1.63% and red Nasdaq futures counsel against chasing. AMD 8-K exhibit

Valuation risk is acute with 10Y at 4.72%. A rising oil/rates pair can overwhelm excellent company fundamentals.

Quantum computing

Extreme speculation

  • Monday: IONQ $46.84 (+1.25%), RGTI $18.67 (−0.80%), QBTS $16.21 (−23.43%), QUBT $9.05 (+0.44%).
  • IonQ Q2 revenue was $80.1M (+287% y/y), but adjusted EBITDA was −$120.3M and adjusted EPS −$0.33; commercial breadth is improving while losses, acquisitions and technical-roadmap execution remain material. SEC exhibit
  • Rigetti Q2 revenue was $5.1M versus a $28.1M operating loss. Its 108Q system reported ~99.1% median two-qubit fidelity versus its longer-term ~99.9% target; scaling without fidelity loss is unproven. Rigetti primary release

All pure plays are high-volatility, pre-profit and dilution/contract-timing sensitive. No useful quantum advantage was independently established by today's price moves.

Peptide drugs & metabolic platforms

Fundamental leader: LLY NVO / VKTX

  • LLY $1,183.16 (+0.25%): scaled Mounjaro/Zepbound sales and Phase 3 retatrutide efficacy remain the quality anchor, but reimbursement, manufacturing, GI/tolerability and valuation risks demand staged entries. Lilly retatrutide release
  • TRIUMPH-3 was randomized, double-blind Phase 3, n=1,946, with week-80 body-weight endpoint. Lilly reported −28.3% mean weight at 12 mg versus −2.2% placebo; AE discontinuation was 11.3% versus 4.9%. Registry and detailed publication still matter. ClinicalTrials.gov
  • NVO $44.88 (−2.20%): Novo reported Q2 adjusted operating profit DKK33.389B and raised its outlook; competitive and U.S. pricing risk remain. Novo corporate news

Small-cap VKTX is binary: trial endpoints, estimands, dropout, safety, cash runway and dilution dominate technical setups.

4 · Ranked ideas · conditional paper setups

Risk-off regime means fewer ideas. These are paper setups, not automatic orders. No borrow availability or fee claim is made.

#1 VRT · Vertiv Conditional bullish

NYSE · large-cap · power/cooling · high AI-capex beta

Day: only after market reversal1–4 weeks: applicable3–12+ months: staged

Direction / thesis / catalyst: uncertain positive. Verified Q2 sales, margin and cash-flow growth support mission-critical data-center infrastructure; Aug. 26 NVIDIA results can validate sector demand.

Evidence / counterargument: sales +24%, adjusted operating margin +410 bp and adjusted FCF $925M. Counter: Monday −0.48%, red futures, project timing, customer capex concentration and rich expectations.

Entry / confirmation: no premarket chase; require a U.S. first-hour hold/reclaim of $292–294 with Nasdaq futures/cash improving, or a controlled hold near $285. Invalidation/downside: close below $280, adverse customer-capex signal, margin/guidance cut or oil/rates breakout. Gaps can bypass stops.

Key risks: valuation, hyperscaler concentration, supply/project execution, tariffs, rates and crowded positioning.

Confidence
82
Risk
82
Opportunity
65

#2 NVDA · NVIDIA Conditional bullish

Nasdaq · mega-cap · AI compute/networking · premium event risk

Day: reversal only1–4 weeks: event-sized3–12+ months: staged

Direction / thesis / catalyst: uncertain positive; Monday held $225, and Aug. 26 earnings are the hard catalyst. The broader AI complex was mixed rather than broken.

Evidence / counterargument: relative stability amid oil/rates stress is constructive. Counter: −0.83% Nasdaq futures, extreme expectations, export policy, custom silicon, customer concentration, power/HBM constraints and earnings-gap risk.

Entry / confirmation: require $224–225 hold plus improving semis/breadth; safer confirmation is a high-volume move above the recent range. Invalidation/downside: daily close below $216, material order/guidance miss, adverse export rule or broad AI breakdown.

Key risks: Aug. 26 gap, valuation, competition, supply/power, geopolitical/export controls.

Confidence
83
Risk
86
Opportunity
62

#3 QBTS · D-Wave Quantum Avoid / no knife-catch

NYSE · speculative small-cap quantum · extreme volatility; not a short recommendation

Day: avoid except specialists1–4 weeks: wait for base3–12+ months: venture-sized only

Direction / thesis / catalyst: uncertain bearish/avoid after a verified −23.43% Monday loss. No independently verified primary catalyst was captured, so the thesis is strictly failed-price-action and risk control.

Evidence / counterargument: the outsized break versus quantum peers signals distribution/fragility. Counter: absent confirmed causality, a squeeze or event reversal is possible.

Entry / confirmation: no bearish entry and no borrow claim. Reconsider only after several stable sessions, improving volume/relative strength and primary technical/commercial evidence. Invalidation/downside: avoid stance invalidates on durable base/reclaim; downside worsens on a fresh high-volume low.

Key risks: extreme volatility, dilution, technical validation, lumpy contracts, sentiment, illiquidity during gaps and squeeze risk.

Confidence
76
Risk
98
Opportunity
27

Watchlist · maximum five

Ticker / classClassification & horizonConfirmation / invalidationConfidence / Risk / Opportunity
AMD · Nasdaq large-capAI share-gain watch; swing/long. Q2 data center +107% y/y, but short-term tape weak.Confirm above Monday range with semis; invalidate on guidance/order deterioration or sustained relative weakness.87 / 84 / 61
MU · Nasdaq large-capHBM/memory momentum; day/swing. Monday +4.13%; do not chase gap.Require pullback support and volume; invalidate on failed breakout or adverse memory pricing/guidance.72 / 91 / 58
LLY · NYSE mega-capPeptide leader; swing/long, not day priority.Confirm above $1,200–1,220; invalidate on estimate cuts, material safety/access deterioration or new closing low.90 / 72 / 62
IONQ · NYSE speculativeQuantum milestone watch; specialists/venture only.Require 256Q/QEC evidence, bookings-to-cash conversion and loss control; invalidate on roadmap slip or financing deterioration.79 / 96 / 43
VKTX · Nasdaq small-cap biotechBinary trial watch; swing/venture only.Require endpoint statistics, estimand, dropout, safety and runway; invalidate on weak durability, delay, safety imbalance or dilution.80 / 97 / 55

5 · Changes versus the 2026-08-17 report

ItemPreviousTodayAction
RegimeNeutral / selective risk-onWTI >$85, 10Y 4.72%, Nasdaq futures −0.83%Downgrade to risk-off / event-driven
NVDA#1 conditional bullish; $224 hold$225.01; futures deterioratedRetain but demote #2; reversal confirmation required
VRT#2 momentum bullish$292.43; Q2 fundamentals primary-verifiedPromote #1, still conditional; $280 invalidation retained
AVGOAvoid first bounce$392.43, −0.14%; no fresh breakdownRemove from ranked ideas; remain unranked watch/avoid
QuantumIONQ avoid-chaseQBTS −23.43% outlier; IonQ/Rigetti Q2 now primary-verifiedQBTS becomes avoid; IONQ returns to milestone watch
Oil invalidationWTI >$85 would challenge regimeWTI $85.42, Brent $91.65Trigger hit; risk budget reduced

6 · Important 7–30 day catalysts

Tue Aug. 18 · 08:30–10:00 ET
Housing starts/permits, import/export prices, industrial production and pending home sales. Publication precedes all.
Tue Aug. 18 · after U.S. close
Keysight earnings: test/measurement and AI-networking read-through; verify timing on company IR.
Wed Aug. 19
IonQ at Needham semiconductor/semi-cap conference; demand technical and cash-conversion specifics, not presentation headlines.
Wed Aug. 19 · 14:00 ET
July FOMC minutes: inflation-risk debate, oil sensitivity and reaction function.
Thu–Fri Aug. 20–21
Jobless claims/Philadelphia Fed Thursday; U.S. flash PMI Friday. Retail earnings add consumer evidence.
Wed Aug. 26 · 14:00 PT
NVIDIA Q2 FY27 results—the central AI demand, supply, margin and export-policy gate.
Aug. 26
U.S. GDP second release, durable goods and PCE-related macro calendar concentration raises cross-asset gap risk.
Q3 2026
Viking VK2735 maintenance data: assess effect size, estimand, missing data, discontinuations, safety and cash runway.
Sep. 15–16
FOMC meeting with projections; confirmed by the Federal Reserve.

7 · Bottom line by horizon

Day trade

Default is defense. Do not buy the premarket dip. A paper long is valid only if oil/yields ease and VRT/NVDA reclaim support with broad semiconductor participation. Avoid QBTS knife-catching.

1–4 week swing

Keep size below normal into FOMC minutes and NVIDIA. VRT has the best verified fundamental/technical combination, while NVDA is event-sized. MU momentum is watch-only after its sharp advance.

3–12+ month investment

Prefer cash-generative AI infrastructure and scaled metabolic franchises over pre-profit quantum. Stage entries because long yields and energy inflation can compress even high-quality multiples.

Biggest risk: Hormuz escalation drives Brent through $95, reignites inflation and pushes the 10Y above 4.80% while growth data weaken. Risk-off invalidation: credible de-escalation, WTI below $82, 10Y below 4.65%, VIX below 15 and broad U.S. participation. Trade invalidation: VRT below $280; NVDA below $216; for QBTS, a durable base and reclaimed breakdown level cancels the avoid thesis.

8 · Sources & data quality

Data-quality panel
  • Live timestamp from TZ=Europe/Rome date: 2026-08-18 08:30 CEST.
  • Yahoo chart API was retrieved via query2 at 06:22 UTC after query1 returned HTTP 429. U.S. closes are Aug. 17; Asian data and futures/commodities are Aug. 18 live indications. Treasury curve is official Aug. 17 data.
  • Material company claims use primary IR or SEC sources: NVIDIA, AMD, Vertiv, IonQ, Rigetti, Lilly and ClinicalTrials.gov. Current market narrative was cross-checked against Yahoo's Aug. 17 live recap and official Treasury data.
  • Limitations / retries: Yahoo query1 returned HTTP 429 for a broad quote batch; query2 succeeded. Firecrawl/web extraction rate-limited CNBC, BLS and Census pages; current-news search, direct APIs and official Fed/Treasury alternatives were used. Stooq quote endpoints returned “page does not exist” for all attempted symbols. No price was declared unavailable because Yahoo query2 succeeded. QBTS causality remains unavailable—not enough to claim—after current-news and company/SEC-oriented searches yielded no verified primary explanation; only the price move is asserted.
  • Live indications can change before U.S. cash open. Scores are structured judgments; Confidence measures evidence quality, not probability or guarantee.
  1. Yahoo chart API — S&P 500 (parallel endpoints used for all quoted instruments).
  2. Yahoo Finance — Aug. 17 market recap.
  3. U.S. Treasury — daily curve.
  4. Federal Reserve — FOMC calendar · BLS release schedule.
  5. Vertiv Q2 · AMD 8-K exhibit · NVIDIA event.
  6. IonQ SEC exhibit · Rigetti Q2.
  7. Lilly retatrutide · TRIUMPH-3 registry · Novo Nordisk.